P019: Unfavorable prognostic value of the predominance of THRLBCL-like histopathological growth patterns in nodular lymphocyte-predominant Hodgkin lymphoma (NLPHL)

por Dorokhina, Elena, Moiseeva, T.N., Kovrigina, A.M., Shupletsova, Irirna, Al-Radi, L.S., Chabaeva, Yu. A., Mangasarova, Ya.K.
Publicado 2022

P114: Very late relapses in patients with Hodgkin Lymphoma occuring ≥5 years after initial treament with chemotherapy ± radiotherapy: Treatment strategies and prognostic factors fo...

por Vassilakopoulos, Theodoros P., Liaskas, Athanasios, Rizzuto, Giuliana, Symeonidis, Argyrios, Palma, Marzia, Angelopoulou, Maria K., Giatra, Chara, Kondopidou, Flora, Dimou, Maria, Musseti, Alberto, Xagoraris, Ioanna, Siakantaris, Marina, Verigou, Evgenia, Panitsas, Fotios, Asimakopoulos, John, Arapaki, Maria, Chatzidimitriou, Chrysovalantou, Belia, Marina, Sachanas, Sotirios, Korkolopoulou, Penelope, Cabras, Antonello, Variamis, Eleni, Panayiotidis, Panayiotis, Bakiri, Maria, Karmiris, Themistoklis, Rassidakis, Georgios Z., Corradini, Paolo, Pangalis, Gerassimos, Viviani, Simonetta
Publicado 2022

T100: Long term Follow-up of a Phase I Study Combinations of Ipilimumab, Nivolumab and Brentuximab Vedotin in Patients with Relapsed/Refractory Hodgkin Lymphoma: A trial of the ECO...

por Diefenbach, Catherine, Jegede, Opeyemi, Ambinder, Richard, Cohen, Jonathon, Robertson, Michael, David, Kevin, Advani, Ranjana, Fenske, Timothy, Barta, Stefan, Palmisiano, Neil, Svoboda, Jakub, Morgan, David, Karmali, Reem, Kahl, Brad, Ansell, Stephen M.
Publicado 2022

P025: RADAR: An international phase III, PET response-adapted, randomised trial in progress, comparing ABVD±ISRT with brentuximab vedotin+AVD±ISRT in patients with previously untre...

por Radford, John, Adedayo, Toyin, Ardavan, Arzhang, Barrington, Sally F., Berkahn, Leanne, Chauvie, Stephane, Clifton-Hadley, Laura, Collins, Graham P., Crump, Michael, Cutter, David, Edwards, Darren, Hutchings, Martin, Illidge, Tim, Kirkwood, Amy A., Linton, Kim, Moskowitz, Craig H., Patrick, Pip, Phillips, Beth, Shepherd, Lois, Tonino, Sanne, Trotman, Judith, Williams, Joanna, Doo, Nicole Wong
Publicado 2022

P093: From involved- field to involved-node – Quality analysis of the radiation therapy in HD 17 by the expert panel of the German Hodgkin Study Group

por Oertel, Michael, Hering, Dominik, Nacke, Nina, Kittel, Christopher, Kröger, Kai, Kriz, Jan, Fuchs, Michael, Baues, Christian, Vordermark, Dirk, Engenhart-Cabillic, Rita, Herfarth, Klaus, Lukas, Peter, Schmidberger, Heinz, Marnitz, Simone, Borchmann, Peter, Engert, Andreas, Haverkamp, Uwe, Eich, Hans Theodor
Publicado 2022

P033: Clinical significance of the severity of THRLBCL-like areas in nodular lymphocyte predominant Hodgkin lymphoma

por Shupletsova, Irirna, Kovrigina, Alla, Dorokhina, Elena, Moiseeva, Tatyana
Publicado 2022

P094: Long-term outcomes of bulky classic Hodgkin lymphoma managed with a PET-adapted approach demonstrate excellent outcomes in PET-negative cases

por Kim, Jowon Laura, Villa, Diego, Tonseth, R. Petter, Gerrie, Alina S., Wilson, Don, Benard, Francois, Venner, Chris, Skinnider, Brian, Farinha, Pedro, Slack, Graham W., Scott, David W., Connors, Joseph M., Sehn, Laurie H., Savage, Kerry J.
Publicado 2022

T098: Brentuximab Vedotin plus ESHAP (BRESHAP) versus ESHAP in Patients with Relapsed or Refractory Classical Hodgkin’s Lymphoma. Interim Results of the BRESELIBET Prospective Clin...

por Sureda-Balari, Anna, Terol, M. José, Domingo-Domènech, Eva, Rodriguez, Ana Pilar González, Mohedo, Francisca Hernández, Céspedes, Javier Núñez, De La Cruz Vicente, Fátima, Muñoz, Carmen Martínez, Díaz, M. Elena Amutio, Córdoba, Raul, Izquierdo, Antonia Rodríguez, Domínguez, Samuel Romero, Meijide, Javier Briones, Greil, Richard, Velázquez, Miriam Moreno, Rubio, Araceli, Oteiro, Mariana Bastos, Gómez, Pilar, Avivi, Irit, Casanova, María, Del Campo García, Raquel, Noriega, Victor, Blanco, José Javier Sánchez, Sanz, Ramón. García
Publicado 2022

P045: Plasma proteome profiling of cardiotoxicity in patients with Hodgkin lymphoma

por Ulfstedt, Johan Mattsson, Freyhult, Eva, Christersson, Christina, Mörth, Charlott, Kamali-Moghaddam, Masood, Eriksson, Anna, Enblad, Gunilla, Molin, Daniel
Publicado 2022

T020: Interim PET-guided treatment of early-stage nodular lymphocyte-predominant Hodgkin lymphoma: a subgroup analysis of the GHSG HD16 and HD17 studies

por Eichenauer, Dennis A., Bühnen, Ina, Fuchs, Michael, Greil, Richard, Moccia, Alden, Zijlstra, Josée. M., Hartmann, Sylvia, Kobe, Carsten, Dietlein, Markus, Engert, Andreas, Borchmann, Peter
Publicado 2022

P063: Trial in Progress: Individualized Immunotherapy in Early-Stage Unfavorable Hodgkin Lymphoma - The Investigator-Initiated Phase II GHSG INDIE Trial

por Bröckelmann, Paul J., Kaul, Helen, Fuchs, Michael, Kobe, Carsten, Baues, Christian, Borchmann, Peter, Engert, Andreas
Publicado 2022

T027: High serum levels of Thymus and Activation Related Chemokine (TARC) precede Hodgkin lymphoma diagnosis by several years

por Diepstra, Arjan, Nolte, Ilja M., Van Den Berg, Anke, Levin, Lynn I., Martínez-Maza, Otoniel
Publicado 2022

P034: Correlation between MTV, TLG and Serum TARC Concentration in Classical Hodgkin Lymphoma during First-Line Treatment

por Romano, Ilaria, Puccini, Benedetta, Abenavoli, Elisabetta, Signori, Leonardo, Palazzo, Marianna, Ciceri, Manuel, Sordi, Benedetta, Berti, Valentina, Zizza, Michela, Pancani, Fabiana, Nassi, Luca, Vannucchi, Alessandro Maria
Publicado 2022

P097: The status quo of involved-field radiotherapy – Quality analysis of radiotherapy in the GHSG HD 16

por Oertel, Michael, Hering, Dominik, Kittel, Christopher, Nacke, Nina, Kröger, Kai, Kriz, Jan, Fuchs, Michael, Baues, Christian, Vordermark, Dirk, Engenhart-Cabillic, Rita, Herfarth, Klaus, Lukas, Peter, Schmidberger, Heinz, Marnitz, Simone, Borchmann, Peter, Haverkamp, Uwe, Engert, Andreas, Eich, Hans Theodor
Publicado 2022

P010: Inferior Outcomes for Young Adults Treated on Advanced Stage Clinical Trials: Report from the HoLISTIC Consortium

por Parsons, Susan K., Rodday, Angie Mae, Friedberg, Jonathan W., Gallamini, Andrea, Hawkes, Eliza, Hodgson, David, Johnson, Peter, Link, Brian, Maurer, Matthew, Nelson, Jason, Savage, Kerry J., Upshaw, Jenica, Zinzani, Pier Luigi, Evens, Andrew M.
Publicado 2022

T083: The Effect of Heart Failure on Management and Outcomes of Older Patients with Hodgkin Lymphoma

por Upshaw, Jenica, Nelson, Jason, Rodday, Angie Mae, Kumar, Anita, Klein, Andreas, Konstam, Marvin, Wong, John, Jaffe, Iris, Ky, Bonnie, Friedberg, Jonathan W., Mauer, Matthew, Kent, David, Parsons, Susan K.
Publicado 2022

P056: Variants of the transcription factor ONECUT2 regulate gene expression in Hodgkin Lymphoma cells

por Lein, Patricia, Anchang, Charles Gwellem, Volkmer, Ines, Staege, Martin S.
Publicado 2022

P050: Reed-Sternberg cells accelerate glycolytic and mitochondrial metabolism of tumor microenvironment cells

por Kurlapski, Michał, Szydłowski, Maciej, Braczko, Alicja, Frańczak, Marika, Zieliński, Maciej, Smoleński, Ryszard, Juszczyński, Przemysław, Zaucha, Jan Maciej
Publicado 2022

P041: Low percentage of T lymphocytes in Hodgkin’s Lymphoma lymph nodes, measured by flow cytometry, is associated with inferior progression free survival regardless of negative in...

por Korin, Laura, Cranco, Santiago, Fuente, Lucia, Vitriu, Adriana, Ochoa, Paola, Babuin, Evelina, Gelo, Olivia, Ayala, Luis, Novoa, Andrea, Tempra, Paula, Venegas, Maria Belen, Baron, Anahi Vijnovich, Tartas, Norma, Custidiano, Rosario, Foncuberta, Cecilia, Avalos, Julio Sanchez
Publicado 2022

P018: Treatment outcomes in classical Hodgkin lymphoma (HL): 5-year update report from the Brazilian Prospective Registry

por Biasoli, Irene, Castro, Nelson, Villarim, Carolina Colaço., Traina, Fabiola, Chiattone, Carlos Sergio, Praxedes, Monica, Solza, Cristiana, Perobelli, Leila, Baiocchi, Otavio, Gaiolla, Rafael, Boquimpani, Carla, Buccheri, Valeria, Bonamin Sola, Caroline, Silva, Roberta Oliveira De Paula E., Ribas, Ana Carolina, Steffenello, Giovana, Pagnano, Katia, Soares, Andrea, Medina, Samuel Souza, Silveira, Talita, Cecyn, Karin Zattar, Goveia, Lilian, Palma, Leonardo Carvalho, De Oliveira Marques, Mariana, De Souza, Carmino, Spector, Nelson
Publicado 2022